
When the World Health Organization declared COVID-19 a global health emergency in March 2020, healthcare systems worldwide mobilized to combat a novel viral threat. Yet beneath the surface of this viral crisis, another epidemic was gathering momentum one that will outlast the pandemic itself. In intensive care units where ventilators hummed and personal protective equipment grew scarce, bacteria were evolving. By 2020, resistant hospital-onset infections and deaths had surged by at least 15% across seven major pathogens in U.S. hospitals, with Candida auris increasing by 60% overall. The irony is stark: our efforts to contain a viral pandemic inadvertently dismantled the very antimicrobial stewardship programs and infection controls that had kept bacterial resistance in check for decades.
Vancouver (ICMJE)